drugset / Trial / NCT01516424
Efficiency Study to Investigate Blonanserin in Treatment of Schizophrenia When Compared With Risperidone
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A Randomized, Double-blinded, Double-dummy, Parallel-controlled and Multicenter Clinical trial to Investigate Blonanserin in Treatment of Schizophrenia when compared with Risperidone
Timeline
- Start
- 2012-02
- Primary completion
- 2013-02
- Completion
- 2013-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Blonanserin | Small molecule | 8 mg | — |
| Subject | Blonanserin | Small molecule | 24 mg | — |
| Comparator | Risperidone | Other / unclassified | 2 mg | — |
| Comparator | Risperidone | Other / unclassified | 6 mg | — |